DE PALMA, CLARA
 Distribuzione geografica
Continente #
EU - Europa 7.568
NA - Nord America 7.161
AS - Asia 6.180
SA - Sud America 609
AF - Africa 123
OC - Oceania 64
Continente sconosciuto - Info sul continente non disponibili 5
Totale 21.710
Nazione #
US - Stati Uniti d'America 6.817
IT - Italia 2.111
CN - Cina 2.021
SG - Singapore 1.694
GB - Regno Unito 1.601
DE - Germania 1.525
HK - Hong Kong 553
BR - Brasile 471
RU - Federazione Russa 426
IN - India 395
SE - Svezia 394
VN - Vietnam 389
FR - Francia 355
NL - Olanda 263
CA - Canada 261
BD - Bangladesh 255
KR - Corea 199
FI - Finlandia 159
TR - Turchia 158
IE - Irlanda 141
DK - Danimarca 138
UA - Ucraina 135
ID - Indonesia 118
JP - Giappone 93
BE - Belgio 64
AU - Australia 52
AR - Argentina 51
MX - Messico 48
CI - Costa d'Avorio 47
TW - Taiwan 43
GR - Grecia 39
PH - Filippine 38
ES - Italia 37
EU - Europa 36
PL - Polonia 34
IQ - Iraq 32
AT - Austria 28
CZ - Repubblica Ceca 25
CH - Svizzera 24
CO - Colombia 24
SA - Arabia Saudita 19
TH - Thailandia 18
ZA - Sudafrica 18
PK - Pakistan 16
RO - Romania 16
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 13
CL - Cile 13
MO - Macao, regione amministrativa speciale della Cina 13
EC - Ecuador 12
IL - Israele 12
MY - Malesia 12
NZ - Nuova Zelanda 12
IR - Iran 11
JO - Giordania 10
PY - Paraguay 10
VE - Venezuela 10
EG - Egitto 9
KZ - Kazakistan 9
MA - Marocco 9
SC - Seychelles 9
HU - Ungheria 8
PE - Perù 8
DZ - Algeria 7
JM - Giamaica 7
LT - Lituania 7
MD - Moldavia 7
NP - Nepal 7
BO - Bolivia 6
GT - Guatemala 6
LB - Libano 6
PT - Portogallo 6
AL - Albania 5
TN - Tunisia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EE - Estonia 4
KE - Kenya 4
NI - Nicaragua 4
AM - Armenia 3
BB - Barbados 3
BG - Bulgaria 3
BY - Bielorussia 3
CR - Costa Rica 3
CY - Cipro 3
KG - Kirghizistan 3
LV - Lettonia 3
NG - Nigeria 3
OM - Oman 3
PS - Palestinian Territory 3
QA - Qatar 3
RS - Serbia 3
UY - Uruguay 3
AO - Angola 2
AZ - Azerbaigian 2
GE - Georgia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LC - Santa Lucia 2
LK - Sri Lanka 2
NO - Norvegia 2
Totale 21.720
Città #
Southend 1.385
Singapore 1.021
Milan 860
Ashburn 765
Hanover 741
Hong Kong 479
Fairfield 430
Chandler 399
San Jose 393
Beijing 343
Seattle 310
Dallas 304
Wilmington 260
Frankfurt am Main 239
Houston 210
Council Bluffs 200
Woodbridge 200
Ann Arbor 199
Los Angeles 186
Santa Clara 181
Princeton 151
Cambridge 147
Dublin 139
New York 134
Hefei 130
Dearborn 125
Boardman 110
Ho Chi Minh City 109
Toronto 107
Hanoi 99
Bengaluru 94
Guangzhou 93
Jakarta 87
Lauterbourg 85
Rome 85
Buffalo 81
Helsinki 79
Nanjing 78
Moscow 77
Shanghai 77
Istanbul 76
Jacksonville 74
Mountain View 68
Phoenix 68
Seoul 66
Des Moines 62
Munich 62
Berlin 57
Tokyo 57
Jinan 52
Brussels 50
Redmond 50
Shenyang 50
Abidjan 47
Redwood City 47
São Paulo 46
Columbus 45
Ottawa 45
The Dalles 44
Changsha 36
Cangzhou 34
Chicago 34
Naples 34
Atlanta 32
Nuremberg 30
Turin 30
London 28
Sunnyvale 28
Tianjin 28
Bodio Lomnago 26
Orem 26
Fuzhou 25
Mumbai 24
Warsaw 24
Zhengzhou 24
Edmonton 22
Grafing 22
Monza 22
Wuhan 22
Andover 21
Margão 21
Melbourne 21
Nanchang 21
Sakarya 21
Turku 21
Amsterdam 20
Bari 19
Brno 19
Hangzhou 19
Hebei 19
Taipei 19
Chennai 18
Montreal 18
Paris 18
Piscataway 18
Shenzhen 18
Silver Spring 18
Bogotá 17
Da Nang 17
San Diego 17
Totale 13.209
Nome #
Mitophagy contributes to endothelial adaptation to simulated microgravity 587
Nitric Oxide in Myogenesis and Therapeutic Muscle Repair 462
Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy 443
Evidence of a dual mechanism of action underlying the anti-proliferative and cytotoxic effects of ammonium-alkyloxy-stilbene-based α7- and α9- nicotinic ligands on glioblastoma cells 419
SRT2104, a new SIRT1 activator, is an effective metabolic enhancer that promotes muscle recovery in DMD 410
Defects of full-length dystrophin trigger retinal neuron damage and synapse alterations by disrupting functional autophagy 405
3D Quantitative and Ultrastructural Analysis of Mitochondria in a Model of Doxorubicin Sensitive and Resistant Human Colon Carcinoma Cells 352
Acid Sphingomyelinase Downregulation Enhances Mitochondrial Fusion and Promotes Oxidative Metabolism in a Mouse Model of Melanoma 344
Autophagy as a new therapeutic target in Duchenne muscular dystrophy 338
Autophagy controls neonatal myogenesis by regulating the GH-IGF1 system through a NFE2L2- and DDIT3-mediated mechanism 333
Sfingomielinasi e morte cellulare 332
Drp1 overexpression induces desmin disassembling and drives kinesin-1 activation promoting mitochondrial trafficking in skeletal muscle 324
Increased trophoblast oxygen consumption in IUGR 323
Givinostat as metabolic enhancer reverting mitochondrial biogenesis deficit in Duchenne Muscular Dystrophy 321
Autophagy in the Regulation of Tissue Differentiation and Homeostasis 315
Deficient nitric oxide signalling impairs skeletal muscle growth and performance : involvement of mitochondrial dysregulation 313
Nitric Oxide Generated by Tumor-Associated Macrophages Is Responsible for Cancer Resistance to Cisplatin and Correlated With Syntaxin 4 and Acid Sphingomyelinase Inhibition 313
Sphingolipids and brain resident macrophages in neuroinflammation : an emerging aspect of nervous system pathology 310
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 307
Synergism of nitric oxide and maturation signals on human dendritic cells occurs through a cyclic GMP-dependent pathway 305
Essential role for acid sphingomyelinase-inhibited autophagy in melanoma response to cisplatin 303
The Fine Tuning of Drp1-Dependent Mitochondrial Remodeling and Autophagy Controls Neuronal Differentiation 299
Potent Antiglioblastoma Agents by Hybridizing the Onium-Alkyloxy-Stilbene Based Structures of an α7-nAChR, α9-nAChR Antagonist and of a Pro-Oxidant Mitocan 295
The natural compound climacostol as a prodrug strategy based on pH activation for efficient delivery of cytotoxic small agents 293
Epigenetic modifications of the PGC-1α promoter in Limb Girdle Muscular Dystrophy 2D account for impaired mitochondrial biogenesis : new perspective in HDAC inhibitors as therapeutic strategy of muscular dystrophy I. 275
Modulation of Acid Sphingomyelinase in Melanoma Reprogrammes the Tumour Immune Microenvironment 274
The Suv420h histone methyltransferases regulate PPAR-γ and energy expenditure in response to environmental stimuli 273
Acid sphingomyelinase controls early phases of skeletal muscle regeneration by shaping the macrophage phenotype 266
Muscle-specific Drp1 overexpression impairs skeletal muscle growth via translational attenuation 264
Activation of acid sphingomyelinase and its inhibition by the nitric oxide/cyclic guanosine 3′,5′-monophosphate pathway: Key events in Escherichia coli-elicited apoptosis of dendritic cells 262
Improving the effects of HDAC8 inhibition by combining the activation of SIRT1 in a zebrafish model of Duchenne muscular dystrophy 257
Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy 256
XIAP as a Target of New Small Organic Natural Molecules Inducing Human Cancer Cell Death 253
Dysfunctional autophagy induced by the pro-apoptotic natural compound climacostol in tumour cells 251
Reversal of Defective Mitochondrial Biogenesis in Limb-Girdle Muscular Dystrophy 2D by Independent Modulation of Histone and PGC-1α Acetylation 249
Five-aminosalicylic acid : an update for the reappraisal of an old drug 241
Skeletal muscle homeostasis in Duchenne muscular dystrophy : modulating autophagy as a promising therapeutic strategy 236
High resolution respirometry and MTDNA content in placental cells and tissues of preeclampsia and intrauterine growth restriction 236
Oral administration of plumbagin is beneficial in in vivo models of Duchenne muscular dystrophy through control of redox signaling 235
Assessing the in vivo targeting efficiency of multifunctional nanoconstructs bearing antibody-derived ligands 230
Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies 230
Defective endoplasmic reticulum-mitochondria contacts and bioenergetics in SEPN1-related myopathy 228
RACK1 is evolutionary conserved in satellite stem cell activation and adult skeletal muscle regeneration 218
Nitric oxide inhibition of Drp1-mediated mitochondrial fission is critical for myogenic differentiation 214
Acid sphingomyelinase determines melanoma progression and metastatic behaviour via the microphtalmia-associated transcription factor signalling pathway 213
Ibuprofen-arginine generates nitric oxide and has enhanced anti-inflammatory effects 208
Towards ideal magnetofluorescent nanoparticles for bimodal detection of breast-cancer cells 205
Current Evidence for a Role of Neuropeptides in the Regulation of Autophagy 204
The SIRT1 activator SRT2104 exerts exercise mimetic effects and promotes Duchenne muscular dystrophy recovery 202
The emerging role of acid sphingomyelinase in autophagy 202
Mitochondrial content and function in placental cells and tissues of Preeclampsia and IUGR 199
Nitric oxide confers therapeutic activity to dendritic cells in a mouse model of melanoma 199
TGFβ protects mesoangioblasts from apoptosis via sphingosine kinase-1 regulation 196
In vivo magnetic resonance spectroscopy in the brain of Cdkl5 null mice reveals a metabolic profile indicative of mitochondrial dysfunctions 196
The detrimental effect of Mecp2 null astrocytes on synapses: exploring the molecular mechanisms to find novel druggable targets for Rett syndrome 194
Placental mitochondrial content and function in intrauterine growth restriction and preeclampsia 194
HER2 expression in breast cancer cells is downregulated upon active targeting by antibody-engineered multifunctional nanoparticles in mice 192
SRT2104, a new SIRT1 activator, is an effective metabolic enhancer that promotes muscle recovery in DMD 190
A cellular system to study the role of nitric oxide in cell death, survival, and migration 189
High Resolution Respirometry on placental cells 188
The low-affinity receptor for neurotrophins p75NTR plays a key role for satellite cell function in muscle repair acting via RhoA 184
Nitric oxide, ceramide and sphingomyelinase-coupled receptors: a tale of enzymes and messengers coordinating cell death, survival and differentiation. 182
Nitric oxide and sphingolipids control apoptosis and autophagy with a significant impact on Alzheimer's disease 180
Single-domain protein A-engineered magnetic nanoparticles : toward a universal strategy to site-specific labeling of antibodies for targeted detection of tumor cells 178
Nitric oxide drives embryonic myogenesis in chicken through the upregulation of myogenic differentiation factors 178
Endothelial nitric oxide synthase overexpression by neuronal cells in neurodegeneration : a link between inflammation and neuroprotection 177
The thyroid hormone triiodothyronine controls macrophage maturation and functions : protective role during inflammation 177
MeCP2 deficiency in astrocytes alters synaptogenesis: new insights on Rett syndrome 176
Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors : a novel pathway relevant to the pathophysiology of endothelium 175
Serum starvation affects mitochondrial metabolism of adipose-derived stem/stromal cells 173
Ceramide as a target of chemotherapy : its role in apoptosis and autophagy 168
Characterization of two novel SETX mutations in AOA2 patients reveals aspects of the pathophysiological role of senataxin 168
Nitric oxide and sphingolipids : mechanisms of interaction and role in cellular pathophysiology. 164
MeCP2 deficiency in astrocytes alters synaptogenesis: new insights on Rett syndrome 159
SRT2104, a new specific SIRT1 activator, promotes muscle recovery enhancing mitochondrial metabolism in DMD 159
The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function 158
Nutraceutical strategy to counteract eye neurodegeneration and oxidative stress in drosophila melanogaster fed with high-sugar diet 158
Mecp2 knock-out astrocytes affect synaptogenesis by Interleukin 6 dependent mechanisms 157
Targeting mitochondrial dynamics to tackle duchenne muscular dystrophy progression 155
Endothelial nitric oxide synthase is segregated from caveolin-1 and localizes to the leading edge of migrating cells 142
Neuroprotective role of plumbagin on eye damage induced by high-sucrose diet in adult fruit fly Drosophila melanogaster 142
Targeting mitochondrial dynamics to tackle Duchenne Muscular Dystrophy progression 140
Mitochondria and Reactive Oxygen Species: The Therapeutic Balance of Powers for Duchenne Muscular Dystrophy 134
Impact of Drp1 activation and fission induction in the pathogenesis of DMD progression 133
Antipsychotics and dietary interventions: Pharmacodynamics, pharmacokinetics, and synergisms in therapy 132
Diverse Action of Selected Statins on Skeletal Muscle Cells—An Attempt to Explain the Protective Effect of Geranylgeraniol (GGOH) in Statin-Associated Myopathy (SAM) 131
SRT2104, a new SIRT1 activator, is an effective metabolic enhancer that promotes muscle recovery in DMD 130
Targeting mitochondrial dynamics to tackle Duchenne muscular dystrophy progression 126
Phenotypic gradient from the avascular to the vascular zone of the meniscus : new insights in the use of the term “fibrochondrocytes” referred to meniscus cells 124
Therapeutic potential of HDAC8 Inhibition and SIRT1 activation in Duchenne muscular dystrophy 118
The cross talk between nitric oxide and ceramide: Coordinate interactions among signaling pathways regulating cell death, survival, and differentiation 117
Combination therapy targeting HDAC8 and SIRT1 improves muscle integrity in a dmd zebrafish model 101
null 101
Therapeutic potential of HDAC8 Inhibition and SIRT1 activation in Duchenne muscular dystrophy 92
Reactive Species and Mechanisms of Cell Injury 89
Targeting mitochondrial dynamics to tackle Duchenne muscular dystrophy progression 87
Farmacologia dello stress ossidativo e dei mitocondri 82
Enhancing micro-dystrophin gene therapy: the role of SRT2104, a new Sirtuin1-activating compound, for the treatment of Duchenne Muscular Dystrophy 81
Enhancing micro-dystrophin gene therapy: the role of SRT2104, a new Sirtuin1-activating compound, for the treatment of Duchenne Muscular Dystrophy 76
Retinal damage in a new model of hyperglycemia induced by high-sucrose diets 75
Totale 22.144
Categoria #
all - tutte 60.400
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.400


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021259 0 0 0 0 0 0 0 0 0 0 191 68
2021/20222.309 162 124 152 164 164 137 395 130 280 213 134 254
2022/20231.496 214 151 125 137 147 260 38 94 151 45 94 40
2023/20241.437 51 63 88 117 266 106 45 110 69 115 186 221
2024/20253.657 171 305 116 364 329 206 242 412 211 353 329 619
2025/20266.977 718 560 863 631 645 422 837 342 754 540 665 0
Totale 22.526